endometrial cancer

Showing NaN - NaN of 61

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Endometrial Cancer Trial in Canada, United States (irofulven)

Completed
  • Endometrial Cancer
  • Birmingham, Alabama
  • +39 more
May 24, 2013

Quality of Life in Survivors of Gynecologic Cancer

Completed
  • Endometrial Cancer
  • Ovarian Cancer
  • quality-of-life assessment
  • Birmingham, Alabama
  • +43 more
May 24, 2013

Endometrial Cancer Trial in Houston (medroxyprogesterone, ethinyl estradiol, norgestrel)

Completed
  • Endometrial Cancer
  • Houston, Texas
    M D Anderson Cancer Center
May 2, 2013

Endometrial Cancer Trial in United States (conjugated estrogens)

Terminated
  • Endometrial Cancer
  • conjugated estrogens
  • Birmingham, Alabama
  • +148 more
Apr 10, 2013

Endometrial Cancer Trial in Canada, United States (filgrastim, cisplatin, doxorubicin HCl)

Terminated
  • Endometrial Cancer
  • filgrastim
  • +5 more
  • Birmingham, Alabama
  • +49 more
Apr 10, 2013

Breast Cancer, Endometrial Cancer Trial in United States (medroxyprogesterone, tamoxifen citrate, adjuvant therapy)

Completed
  • Breast Cancer
  • Endometrial Cancer
  • Mobile, Alabama
  • +121 more
Oct 30, 2012

Endometrial Cancer Trial in New York, Houston (Cetuximab)

Completed
  • Endometrial Cancer
  • New York, New York
  • +1 more
Aug 3, 2012

Endometrial Cancer Trial in Houston (Mifepristone)

Completed
  • Endometrial Cancer
  • Houston, Texas
    U.T.M.D. Anderson Cancer Center
Jul 26, 2012

Endometrial Cancer Trial in United States (arzoxifene HCl)

Completed
  • Endometrial Cancer
  • arzoxifene hydrochloride
  • Pasadena, California
  • +9 more
Jun 6, 2012

Breast Cancer, Cervical Cancer, Endometrial Cancer Trial in Houston (fluorouracil, pegylated liposomal doxorubicin HCl,

Unknown status
  • Breast Cancer
  • +3 more
  • Houston, Texas
    University of Texas Health Science Center at Houston
Apr 29, 2009

Breast Cancer, Endometrial Cancer, Ovarian Cancer Trial in Houston (arzoxifene)

Completed
  • Breast Cancer
  • +2 more
  • Houston, Texas
    For information regarding investigative sites for this clinical
May 23, 2007